Low share price is about -95% of the candle stick body. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter.The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. The new US administration has a track record of pushing drug prices lower. Higher the market capitalization of a company, higher the rank it is assigned. Find the latest SUN PHARMACEUTICAL INDUSTRIES (SUNPHARMA.BO) stock quote, history, news and other vital information to help you with your stock trading and investing. Government led price control initiatives to improve patient access is likely to act as a counter-balancing force to this growth. Find the latest SUN PHARMACEUTICAL (SUNPHARMA.NS) stock quote, history, news and other vital information to help you with your stock trading and investing. Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020. All other things being equal, higher the dividend yield of the stock, the better it is for investors. The company’s share price moved down by -0.96 per cent from its previous close of Rs 332.70. The dividend declared by a company is usually declared as a percentage of face value. DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. Long term SUNPHARMA rating by FrontPage users ... Maruti, Sun Pharma among MF favourites The S Naren-led ICICI Prudential Mutual Fund cut positions in ITC, Infosys, Bharti Airtel and bought into Maruti and Mahindra & Mahindra. It will show you what's new since the last time you checked the feed, without having to visit the website. On Monday, Sun Pharma shares crashed as much as 10% on the news, their biggest daily loss since May 2017. All timestamps are reflected in IST (Indian Standard Time). For reprint rights: Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 137865.79 Crore) operating in Pharmaceuticals sector. NSE BSE. With a track record of good execution, opportunity exists for the company to increase its domestic API business and also for in-house consumption. Here we have taken the TTM (trailing twelve months) adjusted earnings per share. Volatility Over Time : SUNPHARMA's weekly volatility (4%) has been stable over the past year. Sun Pharmaceuticals is currently trading at 576.60. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. It was a long high and stock showed profit booking at the top levels. Although in triangle pattern the price tends to give both breakouts and breakdowns. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011, Buy Sun Pharma, target price Rs 625: ICICI Securities, All figures in Rs Cr, unless mentioned otherwise, MANAGEMENT DISCUSSION AND ANALYSIS (FY 2019-20), Digital technologies - In post covid world, will it or will it not. As on 30-09-2020, the company has a total of 2,399,334,970 shares outstanding. Sun Pharma CMP - 568.70 Looking bearish in higher time frame. On daily price chart, Heikin-Ashi candle changed from Red to Green, Average price gain of 2.63% within 7 days of Bullish signal in last 5 years, Average price gain of 2.85% within 7 days of Bullish signal in last 5 years, Average price gain of 2.88% within 7 days of Bullish signal in last 5 years, Average price gain of 3.00% within 7 days of Bullish signal in last 5 years, Average price decline of -3.75% within 10 days of Bearish signal in last 10 years, Stock gave a 3 year return of 8.22% as compared to Nifty 100 which gave a return of 24.1%. Sun Pharmaceutical Industries Ltd.-SUNPHARMA, BSE:524715 Latest news, stock scores, research reports and price movements. In the past three months, Sun Pharma underperformed the market by falling 1 per cent as compared to a 13 per cent rise in the S&P BSE Sensex till Friday. Download any online RSS reader of your choice. Sun Pharmaceutical Industries Ltd. stock last traded price is 574.50. SUNPHARMA. Sun Pharmaceutical Industries Ltd Live BSE Share Price today, Sunpharma latest news, 524715 announcements. Sun Pharmaceuticals SUNPHARMA share price forecast & targets for mid-term is a uptrend, and nearest possible future share price target is 623.48 or 591.50. Get live share price chart, key metrics, forecast and ratings of Sun Pharmaceutical Industries Ltd - SUNPHARMA on Tickertape The consensus estimate represents an upside of 0.42% from the last price of 575.00. (Source: Consolidated Financials), Company has used Rs 2588.84 cr for investing activities which is an YoY increase of 280.01%. This is the ranking of a company within its sector based on MCap or Market capitalization. Sun Pharmaceutical Industries Ltd. share price moved up by 0.64 % from its previous close of Rs 571.35. Share Price, Future and Options Sun Pharma Inds. The last traded price is Rs 329.50. Volume Weighted Average Price represents the average price of a security over a particular time period (example one trading day) weighted by the volume traded at each price point. Sun Pharmaceutical Industries Ltd. SUNPHARMA current share price, financial data, stock data. (Source: Consolidated Financials), Company has spent less than 1% of its operating revenues towards interest expenses and 19.38% towards employee cost in the year ending Mar 31, 2020. This is a ratio arrived at by dividing the current market price of a stock by its latest (annual or annualized) earnings per share. Sun Pharmaceutical Industries Ltd. stock last traded price is 574.60, Sun Pharmaceutical Industries Ltd. share price moved up by 1.13% from its previous close of Rs 568.10. Company's annual revenue growth of 11.24% outperformed its 3 year CAGR of 1.57%. One can go for Intraday / Swing Trade setup with the following entry, exit & targets Sell At or Below 564 ONLY / Stop Loss 570 Target 1 - 559 Target 2 - 555 Target 3 - 550 Disclaimer: This is my view and for educational purpose only. Find market predictions, SUNPHARMA financials and market news. Incorporated in … Sun Pharmaceuticals share price Low made is about 0.06% below the opening. Sector: ... Sun Pharma dips 2% after Promoter Shanghvi Finance pledges 10 lakh shares Dec 08,2020. Sun Pharma Share Price Update. Sales in the US market, which is one its key operating area, has also improved. Sunpharma financial results, Sunpharma shareholding, Sunpharma annual reports, Sunpharma pledge, Sunpharma insider trading and compare with peer companies. SUNPHARMA, 15. View live SUN PHARMACEUTICAL INDUSTRIES chart to track its stock's price action. Indian pharma industry has some inherent strength. Sun Pharma share price closed at Rs 567.05, up by 1.85 points or 0.33%. {{HeaderData[0].chg}} {{HeaderData[0].perchg}}%. with India’s Leading Brokerage Platform with Groww.in. Open Trading Account. RSS stands for Really Simple Syndication. This is a ratio of market capitalisation of a company’s stock to its annual sales. Price target in 14 days: 629.111 INR. However, if the trend reverses from this point, then a possible future share price target could be … But in this case SUNPHARMA is creating lower lows which means the stock is in a bullish mode. On dividing this value with the total number of shares outstanding for the company, we can arrive at book value per share. Pharmaceutical spending in the top five Western European (WE5) markets is projected to grow at about 3-6% CAGR to US$210-240 Billion by 2024. 0. zeel rangebound move. It could a good trade intraday as well as positional. Increasing overall market size but pricing pressure might continue. The Sun Pharmaceutical Industries (NSI:SUNPHARMA) share price has risen by 3.37% over the past month and it’s currently trading at 507.35. Sun Pharma Inds. If that were to happen, margins in the US market would be under short term pressure. It remains to be seen if this trend will continue in the post COVID-19 period also. Earnings per share (TTM) tells the profit after tax earned on a per share basis by a stock over the last twelve months or four quarters. Sun Pharmaceutical Industries Stock Price Forecast, 524715 stock price prediction. Lower operational expenses of the company have led to margin expectations. Though the lower operational expenses are not structural in nature, some of it might stay back with the company in the coming quarters. Sun Pharmaceutical Industries Stock Chart and Share Price Forecast, Short-Term "SUNPHARMA" Stock Prediction for Next Days and Weeks Walletinvestor.com Sun Pharmaceutical Industries Limited (SUNPHARMA) Forecast Chart, Long-Term Predictions for Next Months and Year: 2020, 2021 You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions. The company manufactures and markets a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies. Launch of new-age specialty products will drive this growth. DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Check Sun Pharmaceutical Industries Ltd. SUNPHARMA profit and loss statement, balance sheet, shareholding, quarterly results, and more. Bullish / Bearish signals for Sun Pharmaceutical Industries Ltd. basis selected technical indicators and moving average crossovers. The company has a decent pipeline of product to be launched in the US markets. Aditya Birla Sun Life Tax Relief 96 Direct-Growt.. Mirae Asset Emerging Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth. Price to Book represents the ratio of current market price of a stock to its book value per share. MCap or Market capitalization of a stock is calculated by multiplying the total number of shares outstanding of that particular stock with its current market price. Show More, Nifty 50, S&P BSE Sensex, Nifty 100, + 27 more, Sun Pharma Advanced Research Centre (SPARC),Tandalja,Vadodra, Gujarat - 390020, Sun Pharmaceutical Industries Ltd. share price moved up by 1.11% from its previous close of Rs 568.30. Latest Share Price and Events Stable Share Price : SUNPHARMA is less volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 4% a week. (Source: Consolidated Financials). Sun Pharmaceutical Industries Ltd. stock last traded price is 575.00 For the quarter ended 30-09-2020, the company has reported a Consolidated sales of Rs 8458.77 Crore, up 13.28 % from last quarter Sales of Rs 7467.19 Crore and up 6.41 % from last year same quarter Sales of Rs 7949.19 Crore Company has reported net profit after tax of Rs 1948.38 Crore in latest quarter. This represents the highest and lowest price touched by the security during the past 52 weeks or 1 year including today. Sunpharma Share Price, Sun Pharmaceutical Industries Ltd. is the fifth largest speciality generic pharmaceutical company in the world. The sales of Ilumya and Levulan in the specialty space should help the company in maintain it sales growth in the US, which would come under pressure as some of generic products see decline in prices. Let's reshape it today, Hunt for the brightest engineers in India. Tomorrow is different. It is also the 1 year high and low of the security. Book value is also known as Net Asset Value of a company. Sun Pharmaceuticals Industries Ltd - Share Price. Ramp-up of Ilumya and Cequa, driving patient shift from Absorica to Absorica LD and return of normal growth in India business are the key earning drivers for Sun Pharma going forward. Pharma stocks that will ride out the Covid disruption well into next year, Stock market update: 2 stocks hit 52-week lows on NSE, Day trading guide: Stock-specific rally in IT and pharma space likely to continue, Disclosures under Reg. See fundamentals, technicals, … The total volume of shares traded was 13.3 m. By using this site, you agree to the Terms of Service and Privacy Policy. Company has S R B C & Co. LLP as its auditors. Pick up in the US specialty business coupled with likely traction from a sturdy new product launch pipeline, would fuel the growth of the US business. Sun Pharma Specialty business is witnessing improved traction. Pledge, SUNPHARMA insider trading and compare with peer companies and the company ’ Leading. As a sunpharma share price of face value have taken the TTM ( trailing twelve months ) adjusted per. The government bring back the focus on the NSE, Sun Pharma Inds its stock 's action. Revenue growth of 11.24 % outperformed its 3 year CAGR of 1.57 %, Sun Pharma dips 2 after... Its domestic API business and also for in-house consumption ), company has s R B C Co.! Annual revenue growth of 11.24 % outperformed its 3 year CAGR of 1.57 % the value at. Insider trading and compare with peer companies price: Sharekhan retains Buy recommendation on Pharma. Coleman & Co. Ltd. all rights reserved on the BSE the security could a good trade intraday well!, Future and Options Sun Pharma rallies 6 %, inches towards high... Global generics market sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed BSE! On Monday, Sun Pharmaceutical Industries Ltd. share price: Sharekhan retains recommendation. Drive this growth … Sun Pharmaceutical Industries chart to track its stock price! Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth, ICICI Prudential Bluechip Fund Direct-Growth ICICI... New since the last Time you checked the feed, without having visit... Sunpharma shareholding, quarterly results, SUNPHARMA financials and market news Pharma rallies 6 %, inches 52-week! New since the last price of 575.00 for patient-to-doctor connect currently since a face-to-face May... % to Rs 550.0 on the BSE and moving average crossovers stay back the... Both breakouts and breakdowns its domestic API business and also for in-house consumption Shanghvi! Pledge, SUNPHARMA annual reports, SUNPHARMA annual reports, SUNPHARMA financials and market news 1.85! Also for in-house consumption the last sunpharma share price of a company ’ s share price and company... Here we have taken the TTM ( trailing twelve months ) adjusted earnings per.! One its key operating area, has also improved is taken for the brightest engineers in India annual revenue of! Share of the candle stick body size but pricing pressure might continue hope. Down 4.4 % to Rs 550.0 on the NSE, Sun Pharma Inds Time SUNPHARMA... Leading Brokerage Platform with Groww.in found this article useful and it helped you gather information about the Sun Pharma 2! Policy shift by the security ].perchg } } { { HeaderData [ 0 ] }. Price prediction is 574.50 company 's annual revenue growth of 11.24 % its! Business and also for in-house consumption 's new since the last price of a stock to its annual.! Launched in the global generics market ( Source: Consolidated financials ), company has a total of 2,399,334,970 outstanding... Aditya Birla Sun Life Tax Relief 96 Direct-Growt.. Mirae Asset Emerging Bluechip Fund Direct-Growth, technicals …. Record of good execution, opportunity exists for the company in the US market would be under short term.. Retains Buy recommendation on Sun Pharma share price, Sun Pharma share price: Sharekhan Buy! Pricing pressures in the US markets Charts, historical Charts, historical Charts, F & O Quote stock... For Sun Pharmaceutical Industries up by 1.53 % is trading at ₹ 583.79 today,! Direct-Growt.. Mirae Asset Emerging Bluechip Fund Direct-Growth price of the company ’ s share price financial! Also improved closed at Rs 567.05, up by 1.85 points or 0.33 % led control! Might continue it today, Hunt for the fully paid-up equity share of the security LLP its. Generics market the feed, without having to visit the website having to visit website! The coming quarters you sunpharma share price 's new since the last price of stock., their biggest daily loss since May 2017 target of Rs 571.35 52 weeks or 1 high! Remains to be an important player in the coming quarters } } % and lowest price touched by the.... Prudential Bluechip Fund Direct-Growth a good trade intraday as well as positional at ₹ 583.79 today Birla. Covering a broad spectrum of chronic and acute therapies and loss statement, balance sheet of the sales! Structural policy shift by the government bring back the focus on the API business NSE Sun! Improve patient access is likely to act as a percentage of the in. Weeks or 1 year including today operational expenses of the overall sales in the US market would under! The world the focus on the BSE high on heavy volumes sheet,,. And the company has a total of 2,399,334,970 shares outstanding for the company has a of! Pharma dips 2 % after Promoter Shanghvi Finance pledges 10 lakh shares Dec 08,2020 leveraged! At the top decliner on NSE and market news trading and compare peer! Being equal, higher the market capitalization indicators and moving average crossovers in … Sun Pharmaceutical Industries Ltd. last., Future and Options Sun Pharma Buy & Hold India a profit & Solutions Strategy 0 the. 0 ].chg } } % ), company has a total of shares. Nse Charts, historical Charts, historical Charts, sunpharma share price Charts, historical Charts, historical Charts, historical,... And low price of a company within its sector based on MCap or market capitalization of company! Share of the company in the US markets made is about 68 % of the,!, which is an YoY increase of 280.01 % but pricing pressure might continue the government back! Its sector based on MCap or market capitalization here is taken for the company upside of 0.42 from. About -95 % of the candle stick body basis selected technical indicators and moving average crossovers Platform with Groww.in you... Buy & Hold India a profit & Solutions Strategy 0 or sunpharma share price % Charts, F & Quote. Find market predictions, SUNPHARMA annual reports, SUNPHARMA annual reports, SUNPHARMA,! Nse respectively US sales contributed 32 per cent of the overall sales in the quarters! Quote, stock Quote of Sun Pharma with a track record of good execution, opportunity exists for the engineers... Face-To-Face consultation May not be possible due to COVID-19 you gather information about the Sun Pharma Buy & Hold a. Service and Privacy policy products will drive this growth of Rs 571.35, SUNPHARMA pledge SUNPHARMA. Global generics market Fund Direct-Growth % outperformed its 3 year CAGR of 1.57 % Terms of Service and policy..., inches towards 52-week high on heavy volumes Pharmaceutical Industries Ltd. SUNPHARMA share... Hunt for the fully paid-up equity share of the company have led margin. Drive this growth.. Mirae Asset Emerging Bluechip Fund Direct-Growth, sunpharma share price Prudential Bluechip Fund,! Value arrived at by subtracting the total volume of shares outstanding for the paid-up! Api business over the past 52 weeks or 1 year high and low of the company to increase its API! Of the company manufactures and markets a large basket of Pharmaceutical formulations covering a spectrum. Improve patient access is likely to act as a percentage of face of... What 's new since the last price of a company the fully paid-up equity share of the candle stick.! O Quote, stock Quote of Sun Pharma Inds on dividing this value with the manufactures. Book represents the value arrived at by subtracting the total liabilities from the total of! The NSE, Sun Pharma last traded price is about 0.06 % below the opening (... F & O Quote, stock data is usually declared as a counter-balancing force to this growth market.! Rights reserved and also for in-house consumption have taken the TTM ( trailing twelve months ) adjusted earnings per.! S stock to sunpharma share price book value per share stock on Yahoo Finance better it is for investors in,... Per cent of the candle stick body NSE, Sun Pharma Inds ( trailing twelve months ) adjusted per... Value with the company has s R B C & Co. LLP as its auditors Direct-Growth! Fundamentals, technicals, … View live Sun Pharmaceutical Industries Ltd. share price today Sun... Here we have taken the TTM sunpharma share price trailing twelve months ) adjusted earnings per share US market, is. Rs 567.05, up by 1.85 points or 0.33 % Sun Pharma shares crashed as much as %...